SELVITA S.A. SER.B ZY-,80

SELVITA S.A. SER.B ZY-,80 Share · PLSLVCR00029 · A2PTJJ (XWAR) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of SELVITA S.A. SER.B ZY-,80
No Price
Closing Price XWAR 30.04.2026: 35,00 PLN
30.04.2026 17:31
Current Prices from SELVITA S.A. SER.B ZY-,80
ExchangeTickerCurrencyLast TradePriceDaily Change
XDUS: Düsseldorf
Düsseldorf
SSAIAS29.DUSB
EUR
30.04.2026 17:31
7,79 EUR
-
XWAR: WSE
WSE
SLV.WA
PLN
30.04.2026 15:00
35,00 PLN
0,15 PLN
+0,43 %
XDQU: Quotrix
Quotrix
SSAIAS29.DUSD
EUR
30.04.2026 05:27
8,09 EUR
-
Share Float & Liquidity
Free Float 76,91 %
Shares Float 14,12 M
Shares Outstanding 18,35 M
Company Profile for SELVITA S.A. SER.B ZY-,80 Share
Selvita S.A. operates as a contract research organization in Poland, rest of Europe, the United States, and internationally. It operates in two segments, Contract Research Organization (CRO) services, and Bioinformatics. The company offers drug discovery services in the areas of assay development and screening, medicinal and synthetic chemistry, computer-aided drug design/ artificial intelligence, structural biology, in vitro/ In Vivo pharmacology, ADME/DMPK and analytical testing. It also provides pharma services in the field of drug testing and bioanalytical analysis, including development and optimization, validation and transfer, stability studies, quality control, and regulatory aspects support services. In addition, the company offers research and development services in the areas of process research, laboratory scale custom synthesis of NCEs, industrial chemistry, and synthesis of isotopically labelled compounds, as well as other services for the agrochemical industry. Further, it provides bio-data science and advanced software services to data-driven life science and healthcare organizations. Selvita S.A. was founded in 2007 and is headquartered in Krakow, Poland.

Company Data

Name SELVITA S.A. SER.B ZY-,80
Company Selvita S.A.
Website https://selvita.com
Primary Exchange XWAR WSE
WKN A2PTJJ
ISIN PLSLVCR00029
Asset Class Share
Sector Healthcare
Industry Medical - Diagnostics & Research
CEO Boguslaw Stanislaw Sieczkowski
Market Capitalization 642 Mio
Country Poland
Currency EUR
Employees 1,0 T
Address ul. Bobrzynskiego 14, 30-348 Kraków
IPO Date 2019-10-17

Ticker Symbols

Name Symbol
Düsseldorf SSAIAS29.DUSB
Frankfurt 787.F
Quotrix SSAIAS29.DUSD
WSE SLV.WA
More Shares
Investors who hold SELVITA S.A. SER.B ZY-,80 also have the following shares in their portfolio:
LB.HESS.THR.CARRARA04P/21
LB.HESS.THR.CARRARA04P/21 Bond
NATIONAL GRID NORTH AMERICA INC. 2.7425% ISNT 08/04/22
NATIONAL GRID NORTH AMERICA INC. 2.7425% ISNT 08/04/22 Bond